IDiyas

For the Inventor, By the Inventor

Cedar Grove, NJ, United States of America

James Valentine Earley

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:

goldMedal12 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1995

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5428004 - Compounds useful as dual antagonists of platelet activating factor and (1995-06-27),
2. 5302590 - Compounds useful as dual antagonists of platelet activating factor and (1994-04-12),
3. 5141735 - Substituted amino-benzodiazepines having anitviral activity (1992-08-25),
4. 4777169 - Benzodiazepine derivatives (1988-10-11),
5. 4049667 - Tricyclic benzodiazepines (1977-09-20),
6. 4049666 - Tricyclic benzodiazepines (1977-09-20),
7. 4017532 - Intermediates for the production of tricyclic benzodiazepines (1977-04-12),
8. 4017531 - Intermediates for the production of tricyclic benzodiazepines (1977-04-12),
9. 4014916 - Intermediates in the production of tricyclic benzodiazepines (1977-03-29),
10. 3997591 - Tricyclic benzodiazepines (1976-12-13),
11. 3997591 - Tricyclic benzodiazepines (1976-12-13),
12. 3965151 - Intermediates for tricyclic benzodiazepines (1976-06-22),

Title: James Valentine Earley: Innovator in Pharmaceutical Compounds

Introduction

James Valentine Earley is a notable inventor based in Cedar Grove, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that serve as dual antagonists of platelet activating factor. With a total of 12 patents to his name, Earley's work has had a considerable impact on medical science.

Latest Patents

Earley's latest patents focus on compounds that are useful as bronchopulmonary agents. These compounds are designed to provide relief for conditions such as asthma and allergic reactions. The invention details specific chemical formulas, including variations of R groups that can include hydrogen, lower alkyl, and cycloalkyl structures. The compounds are also described as having potential pharmaceutical applications, including methods of use and formulations.

Career Highlights

James Valentine Earley has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to explore innovative solutions to complex medical challenges. His contributions have been recognized within the industry, showcasing his expertise in pharmaceutical chemistry.

Collaborations

Earley has collaborated with notable colleagues, including Michael Edward Derieg and Rodney I Fryer. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

James Valentine Earley is a distinguished inventor whose work in pharmaceutical compounds has the potential to improve the quality of life for many individuals suffering from respiratory conditions. His innovative spirit and dedication to research continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…